Percodan and Hyperhidrosis - a phase IV clinical study of FDA data

Summary:

Hyperhidrosis is reported as a side effect among people who take Percodan (aspirin; oxycodone hydrochloride; oxycodone terephthalate), especially for people who are female, 60+ old, also take Vicodin, and have Sleep disorder.

The phase IV clinical study analyzes which people have Hyperhidrosis when taking Percodan. It is created by eHealthMe based on reports of 12,849 people who have side effects when taking Percodan from the FDA, and is updated regularly.

What is Percodan?

Percodan has active ingredients of aspirin; oxycodone hydrochloride; oxycodone terephthalate. It is often used in pain. eHealthMe is studying from 12,885 Percodan users. Check the latest studies of Percodan.

What is Hyperhidrosis?

Hyperhidrosis (abnormally increased sweating) is found to be associated with 2,614 drugs and 3,519 conditions by eHealthMe. Check the latest studies of Hyperhidrosis.

On Sep, 17, 2025

12,849 people reported to have side effects when taking Percodan.
Among them, 16 people (0.12%) have Hyperhidrosis.

Among these 16 people:

What is the gender of people who have Hyperhidrosis when taking Percodan? *

female: 56.25 %
male: 43.75 %

What is the age of people who have Hyperhidrosis when taking Percodan? *

What are other drugs people take besides Percodan? *

What are other side effects people have besides Hyperhidrosis? *

Constipation: 8 people, 50.00%
Depression: 7 people, 43.75%
Insomnia (sleeplessness): 7 people, 43.75%
Nausea And Vomiting: 6 people, 37.50%
Weight Decreased: 5 people, 31.25%
Nausea (feeling of having an urge to vomit): 5 people, 31.25%
Hot Flush (sudden feelings of heat): 5 people, 31.25%
Neuralgia (pain in one or more nerves): 4 people, 25.00%
Memory Loss: 4 people, 25.00%
Joint Pain: 4 people, 25.00%

What are the existing conditions these people have? *

Migraine (headache): 4 people, 25.00%
Insomnia (sleeplessness): 4 people, 25.00%
Breakthrough Pain: 4 people, 25.00%
Sleep Disorder: 4 people, 25.00%
Stress And Anxiety: 3 people, 18.75%
Indigestion: 2 people, 12.50%
Depression: 2 people, 12.50%
Back Pain: 2 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%
Headache (pain in head): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Percodan and have Hyperhidrosis?

- Check whether Hyperhidrosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Percodan:

Percodan (12,885 reports)

Hyperhidrosis treatments and more:

Hyperhidrosis (147,205 reports)

How severe was Hyperhidrosis and when was it recovered:

Hyperhidrosis in Percodan

Browse all side effects of Percodan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperhidrosis:

Hyperhidrosis (2,614 drugs)

Browse all the conditions that are associated with Hyperhidrosis:

Hyperhidrosis (3,519 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aspirin; oxycodone hydrochloride; oxycodone terephthalate (the active ingredients of Percodan) and Percodan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.